about
De novo mutations in epileptic encephalopathiesCentrotemporal sharp wave EEG trait in rolandic epilepsy maps to Elongator Protein Complex 4 (ELP4).Resting functional connectivity between the hemispheres in childhood absence epilepsyAssociation of MTOR Mutations With Developmental Brain Disorders, Including Megalencephaly, Focal Cortical Dysplasia, and Pigmentary Mosaicism.Dynamic time course of typical childhood absence seizures: EEG, behavior, and functional magnetic resonance imaging.Simultaneous EEG, fMRI, and behavior in typical childhood absence seizuresThe genetics of reading disability in an often excluded sample: novel loci suggested for reading disability in Rolandic epilepsy.Growth hormone-releasing hormone effects on brain γ-aminobutyric acid levels in mild cognitive impairment and healthy aging.Impaired attention and network connectivity in childhood absence epilepsy.Comparison of subdural and subgaleal recordings of cortical high-gamma activity in humans.Stereotactic laser ablation for hypothalamic and deep intraventricular lesions.Inherited disorders of neurotransmitters in children and adults.Local functional connectivity as a pre-surgical tool for seizure focus identification in non-lesion, focal epilepsy.Regional Patterns of Cortical Phase Synchrony in the Resting State.Functional MRI connectivity as a predictor of the surgical outcome of epilepsy.Evidence for linkage of migraine in Rolandic epilepsy to known 1q23 FHM2 and novel 17q22 genetic loci.Early-Life Epilepsies and the Emerging Role of Genetic Testing.Corticospinal tract atrophy and motor fMRI predict motor preservation after functional cerebral hemispherectomy.Electrocorticography and the early maturation of high-frequency suppression within the default mode network.Impact of epilepsy surgery on development of preschool children: identification of a cohort likely to benefit from early intervention.Microscopic brain structure revisited in genetic epilepsy.A decrease in EEG energy accompanies anti-epileptic drug taper during intracranial monitoring.Early genetic testing for neonatal epilepsy: When, why, and how?
P50
Q24621776-AF4100C1-DB08-4622-A935-56A26EEA3738Q24648625-810A69B8-2C90-4D14-A03D-BF1292A819CEQ28743898-2846EEAD-30CD-45EF-90EC-46D140AC479BQ30276841-EA631B4D-33CA-4A61-A217-76F37AEFDB4AQ30496751-615D7DE2-B279-49F2-BED8-ADAEFBFD8FD7Q34192391-640FD46B-853A-4245-B74F-6687FC815C7EQ34345047-3C62B5C2-A0AA-43A5-BF48-FC60CE449D85Q34652032-D4F6180D-C7E7-4DBF-8400-EF8395336F02Q35017070-57C74202-3A4B-4937-9223-01C67E75D53AQ36143294-1E4692D6-1065-4859-AD58-9BEC0D75B7AFQ36150164-B4487880-49DE-4C78-92E8-630367B45360Q36317825-5DD61815-FBE6-4DF9-92A9-7AEB44B32846Q36806066-95CC458F-AAB3-4119-ABAF-0B20EF76785FQ37157088-618F8A8F-D58A-4E5C-9F84-CAFBA1665CC3Q38361419-0601CD5D-CE09-4594-BEA1-BD4F600E4673Q45217603-75DF4FAD-5AD4-4493-851E-DED7DDA9BFEAQ45947607-05BC78D4-854F-44A7-A06B-CAB672ED2C2BQ46064654-2F5CCBC4-379F-4960-B979-954CE5F809D8Q47203325-CA936DE8-3E89-47F8-9552-02C2608B718BQ48096304-53E88CC8-28AF-4CAC-A401-25F72D248D2DQ48296969-F2DA0726-BC15-41A0-96FF-D8C17D8D80F4Q48506163-EB8E347D-2B92-4FCE-95B0-92C044936CABQ54285480-5958303D-9E41-4761-8AF5-63B4BAF36115
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Edward J Novotny
@nl
Edward J Novotny
@sl
Edward J. Novotny
@en
Edward J. Novotny
@es
type
label
Edward J Novotny
@nl
Edward J Novotny
@sl
Edward J. Novotny
@en
Edward J. Novotny
@es
prefLabel
Edward J Novotny
@nl
Edward J Novotny
@sl
Edward J. Novotny
@en
Edward J. Novotny
@es
P106
P1153
7004406252
P21
P31
P496
0000-0001-9726-0447